Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ethyl bromoacetate | HCID 7748 | — |
| Reactant | Allylamine | HCID 7853 | — |
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | Benzyl chloroformate | HCID 10387 | — |
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Solvent | Sodium chloride; water | HCID 57417360 | — |
| Product | Carbamate | HCID 276 | 217.9% |
| Product | N-2-Propen-1-ylglycine ethyl ester | HCID 10975597 | — |
Reaction Steps
N-Allylglycine ethyl ester 54 was prepared as described above using ethyl bromoacetate (9 g, 53.9 mmol) and allylamine (6.15 g, 107.7 mmol). The crude product (7.054 g) that contained ˜30% of N-allyl-N-bis(2-carboethyoxyethyl)amine as judged by NMR, was dissolved in dichloromethane (50 cm3), cooled to 0° C. and triethylamine (6.53 g, 64.09 mmol) added. Benzylchloroformate (9.25 g, 54.2 mmol) was added dropwise over 10 min resulting in a white precipitate. After 2 h the mixture was stored overnight at 0° C., filtered and the filtrate concentrated in vacuo. The residue was subsequently suspended in dichloromethane, washed with 2M aqueous hydrochloric acid, dried (MgSO4) and the solvent removed to reveal an oil (13.65 g) containing the desired carbamate (70%) and benzyl alcohol (30%) as judged by NMR. This mixture was dissolved in dioxane/methanol (8:3, 110 cm3), 1M aqueous sodium hydroxide (40 cm3, 40 mmol) added and the solution stirred for 2 h at room temperature. Brine (50 cm3) was added and the aqueous layer extracted with diethyl ether. The aqueous layer was acidified with 32% hydrochloric acid and extracted with ethyl acetate. The combined organic layers were dried (MgSO4), concentrated in vacuo, and the residue purified by chromatography (silica gel, hexane:ethyl aceate:acetic acid, 3:1:0.4) to give acid 7 (7.05 g, 52%, 3 steps) as a colourless syrup. Acid 55 existed as a 1:1 mixture of carbamate rotamers: δH (400 MHz; CDCl3; Me4Si) 4.02-4.08 [4H, m, CH2(allyl), C2(Gly)], 5.17-5.24 (4H, m, OCH2Ph, ═CH2), 5.77-5.84 (1H, m, C(H)═CH2), 7.32-7.39 (m, 5H, Ph) and 8.45 (1H, br s, OH); δC (100 MHz; CDCl3) 47.1, 47.7 [CH2, CH2(Gly)], 50.5, 50.7 [CH2, CH2(allyl)], 67.6, 67.7 (CH2, OCH2Ph), 117.8, 118.3 (CH2, ═CH2), 127.7, 127.97, 128.01, 128.4, (CH, Ph), 132.7, 132.8 (CH, C(H)═CH2) 136.1 (quat., Ph), 155.8, 156.5, (quat., NCO2) and 174.7, 174.9 (quat., CO).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08013170B2 |
|---|
| Source dataset | uspto-grants-2011_09 |
|---|
| ORD ID | ord-235cc3e83dfc4484b306b2a3c85369dd |
|---|
| Source note | uspto-grants-2011_09 |
|---|